
Pharmaceutical Sourcing and Onshoring Survey - 2022 Edition
Description
Pharmaceutical Sourcing and Onshoring Survey - 2022 Edition
Summary
Recent geopolitical events are causing the pharma industry to consider its supply chain more carefully than ever. Highly developed pharma markets rely on foreign suppliers for their drugs, especially China and India. The COVID-19 pandemic, rising raw material and fuel costs, Russia’s war against Ukraine, and other events are prompting industry conversations about drug shortages and supply chain security.
In this report, GlobalData assesses the outlook for pharmaceutical supply chains over the next 12 months, to determine to what extent bio/pharmaceutical companies and their service providers are concerned, and whether they plan to “onshore” or “offshore” their manufacturing steps.
Scope
Who should buy this report?
Summary
Recent geopolitical events are causing the pharma industry to consider its supply chain more carefully than ever. Highly developed pharma markets rely on foreign suppliers for their drugs, especially China and India. The COVID-19 pandemic, rising raw material and fuel costs, Russia’s war against Ukraine, and other events are prompting industry conversations about drug shortages and supply chain security.
In this report, GlobalData assesses the outlook for pharmaceutical supply chains over the next 12 months, to determine to what extent bio/pharmaceutical companies and their service providers are concerned, and whether they plan to “onshore” or “offshore” their manufacturing steps.
Scope
Who should buy this report?
- This 36-page report gives important, expert insight you won’t find in any other source. 17 figures throughout the report illustrate major points and trends. This report is required reading for:
- CMO executives who must have deep understanding of the pharmaceutical supply chain to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
- Overview of supply chain trends and key stakeholders' attitudes to onshoring and sourcing
- Detailed survey of industry plans to change sourcing strategy
- Analysis by geography, drug molecule type, company type, manufacturing step (active pharmaceutical ingredient, finished dose form, packaging)
Table of Contents
36 Pages
- Objectives and Design
- Survey Respondent Mix
- Survey Respondent Profiles
- The Pharma Supply Chain
- Onshoring - What’s at Stake?
- API Onshoring Plans - by Geography
- Dose/Packaging Onshoring Plans - by Geography
- What Does It Mean?
- Onshoring So Far
- Onshoring Plans - by Drug Type
- Onshoring - Will It Work?
- Challenges for the Next 12 Months - by Company Geography
- Challenges for the Next 12 Months - by Company Business Model
- Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.